3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Multiple Myeloma
4
Barrett Esophagus
3
Venous Thromboembolism
2
Tobacco Use Disorder
2
Prostatic Neoplasms
2
Precancerous Conditions
2
Polycythemia Vera
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Vascular Diseases
1
Triple Negative Breast Neoplasms
1
Thromboembolism
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stroke
1
Soft Tissue Neoplasms
1
Smoking Cessation
1
Sarcoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Pulmonary Nodules
1
Interventions
pralsetinib
2
pembrolizumab
2
Brentuximab Vedotin
2
Bevacizumab
2
ribociclib
1
fosaprepitant
1
Sunitinib
1
Sirolimus
1
Radiotherapy, Image-Guided
1
Plicamycin
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Genistein
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dexamethasone
1
Cisplatin
1
Carboplatin
1
Aprepitant
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Germ Cell and Embryonal
×
Aspirin
×
Clear all
No trials found.